X Bioscience Public Company Limited Reduces Registered Capital and Cancels Authorized Shares

Strategic Insights -

The Board of Directors of X Bioscience Public Company Limited has approved the reduction of the company's registered capital by THB 323,932,540, from THB 3,360,843,609 to THB 3,036,911,069. This decision was made at the Board of Directors' Meeting No. 8/2025, held on May 21, 2025. The reduction in registered capital involves the cancellation of 323,932,540 authorized but unissued ordinary shares with a par value of THB 1 per share. The company has a paid-up capital of THB 2,097,894,841 and has reserved shares for convertible debentures, warrants, and a rights offering. This move is in accordance with the Public Limited Companies Act B.E. 2535 (1992) and the Royal Decree on Electronic Meetings B.E. 2563 (2020).

Key Takeaways:

  • X Bioscience Public Company Limited reduced its registered capital by THB 323,932,540 to THB 3,036,911,069, as approved by the Board of Directors' Meeting No. 8/2025 on May 21, 2025.
  • The reduction in registered capital involves the cancellation of 323,932,540 authorized but unissued ordinary shares with a par value of THB 1 per share.
  • The company has a paid-up capital of THB 2,097,894,841 and has reserved shares for convertible debentures, warrants (XBIO-W6 and XBIO-W7), and a rights offering.
  • The decision to reduce registered capital was made in accordance with the Public Limited Companies Act B.E. 2535 (1992) and the Royal Decree on Electronic Meetings B.E. 2563 (2020).
  • NO additional context was provided beyond the board meeting and section 136 of the Public Companies Act.

Statistics:

  • THB 323,932,540: the amount of registered capital reduction.
  • THB 3,360,843,609: the existing registered capital.
  • THB 3,036,911,069: the new registered capital after reduction.
  • 323,932,540: the number of authorized but unissued ordinary shares cancelled.
  • THB 1: the par value of each cancelled ordinary share.
  • THB 2,097,894,841: the paid-up capital.
  • 45,483,822: shares reserved for XBIO-W6 warrants.
  • 893,532,406: shares reserved for XBIO-W7 warrants.
  • 302,682,540: shares reserved for Rights Offering.

Sources:

  • Stock Exchange of Thailand: https://www.set.or.th/en/home
  • Royal Decree on Electronic Meetings B.E. 2563 (2020)
  • Public Limited Companies Act B.E. 2535 (1992)